Literature DB >> 26767651

Skeletal health in adult growth hormone deficiency.

Nicholas A Tritos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26767651     DOI： 10.1007/s12020-016-0859-z

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  10 in total

1.  Treatment of a pituitary dwarf with human growth hormone.

Authors:  M S RABEN
Journal:  J Clin Endocrinol Metab       Date:  1958-08       Impact factor: 5.958

2.  The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. .

Authors:  C Wüster; R Abs; B A Bengtsson; H Bennmarker; U Feldt-Rasmussen; E Hernberg-Ståhl; J P Monson; B Westberg; P Wilton
Journal:  J Bone Miner Res       Date:  2001-02       Impact factor: 6.741

3.  Effect of growth hormone on skeletal mass in adult dogs.

Authors:  W H Harris; R P Heaney
Journal:  Nature       Date:  1969-07-26       Impact factor: 49.962

4.  Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency.

Authors:  Gherardo Mazziotti; Mauro Doga; Stefano Frara; Filippo Maffezzoni; Teresa Porcelli; Luigi Cerri; Roberto Maroldi; Andrea Giustina
Journal:  Endocrine       Date:  2015-10-03       Impact factor: 3.633

Review 5.  Pituitary diseases and bone.

Authors:  Gherardo Mazziotti; Silvia Chiavistelli; Andrea Giustina
Journal:  Endocrinol Metab Clin North Am       Date:  2014-11-04       Impact factor: 4.741

6.  Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy.

Authors:  Gherardo Mazziotti; Antonio Bianchi; Stefania Bonadonna; Monica Nuzzo; Vincenzo Cimino; Alessandra Fusco; Laura De Marinis; Andrea Giustina
Journal:  J Bone Miner Res       Date:  2006-04-05       Impact factor: 6.741

7.  Fracture risk is increased in patients with GH deficiency or untreated prolactinomas--a case-control study.

Authors:  Peter Vestergaard; Jens Otto L Jørgensen; Claus Hagen; Hans Christian Hoeck; Peter Laurberg; Lars Rejnmark; Kim Brixen; Jørgen Weeke; Marianne Andersen; Flavia L Conceicao; Torben Leo Nielsen; Leif Mosekilde
Journal:  Clin Endocrinol (Oxf)       Date:  2002-02       Impact factor: 3.478

8.  Bone status and fracture prevalence in Russian adults with childhood-onset growth hormone deficiency.

Authors:  R Bouillon; E Koledova; O Bezlepkina; J Nijs; E Shavrikhova; E Nagaeva; O Chikulaeva; V Peterkova; I Dedov; A Bakulin; V Oganov; A F Attanasio
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

Review 9.  Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis.

Authors:  Maya Barake; Anne Klibanski; Nicholas A Tritos
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

10.  Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency.

Authors:  Mariam Elbornsson; Galina Götherström; Ingvar Bosæus; Bengt-Åke Bengtsson; Gudmundur Johannsson; Johan Svensson
Journal:  Eur J Endocrinol       Date:  2012-02-08       Impact factor: 6.664
  10 in total
  1 in total

1.  Recombinant growth hormone treatment, osteoporosis and fractures, more complicated than it seems!

Authors:  Maria Fleseriu
Journal:  Endocrine       Date:  2018-01-19       Impact factor: 3.633
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.